Matthew Gline
Förmögenhet: 590 M $ per 2026-06-30
Förmögenhet: 590 M $ per 2026-06-30
Matthew Gline is the founder of Fourthrev Ltd., founded in 2012.
Current jobs include Chief Executive Officer & Director at Roivant Sciences Ltd. since 2021, Chief Executive Officer at Roivant Sciences GmbH since 2021, Chief Executive Officer at Roivant Sciences, Inc. since 2021, Secretary & Director at Roivant Social Ventures, Inc. since 2016, Director at Datavant, Inc., and Independent Director at Arbutus Biopharma Corp.
starting in 2025.
Former jobs include Chief Executive Officer & Director at Montes Archimedes Acquisition Corp., Director at Urovant Sciences Ltd., Director at Sumitovant Biopharma, Inc., Vice President at Barclays PLC from 2008 to 2012, and Vice President at Goldman Sachs & Co. LLC from 2014 to 2016.
Education includes undergraduate studies at Harvard College.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
ROIVANT SCIENCES LTD. 2,32 % | 2026-06-30 | 16 659 945 ( 2,32 % ) | 590 M $ | 2026-06-30 |
| Företag | Position | Start |
|---|---|---|
| ROIVANT SCIENCES LTD. | Verkställande Direktör | 2021-01-01 |
| ARBUTUS BIOPHARMA CORPORATION | Direktör/Styrelseledamot | 2025-02-24 |
Roivant Sciences GmbH
Roivant Sciences GmbH Pharmaceuticals: MajorHealth Technology Develops and markets biopharmaceutical products | Verkställande Direktör | 2021-01-01 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Verkställande Direktör | 2021-01-01 |
Roivant Social Ventures, Inc.
Roivant Social Ventures, Inc. Roivant Social Ventures, Inc. is a not-for-profit social impact organization dedicated to advancing health equity by applying private sector strategies to biopharma innovation and healthcare delivery. The private company is based in New York, NY. The company focuses on ensuring equitable access to medicines and medical care regardless of geography, wealth, or insurance status by investing in early-stage companies developing therapies for underserved patient populations, incubating healthcare-focused social entrepreneurs, and embedding drug development education in academic institutions through fellowships and internships to promote diversity in the biopharma industry and clinical trials. Roivant Social Ventures also partners with companies, institutes, and organizations to create systemic improvements in healthcare access and delivery, with key focus areas including gene therapy access, increasing diversity in clinical trials, and fostering diversity, equity, and inclusion opportunities for future biopharma leaders. Lindsay Androski has been the CEO of the company since 2016. | Direktör/Styrelseledamot | 2016-03-01 |
Datavant, Inc.
Datavant, Inc. Packaged SoftwareTechnology Services Operates as a health care software data platform company | Direktör/Styrelseledamot | - |
| Företag | Position | Slut |
|---|---|---|
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Företagsledare/Principal | 2016-01-01 |
Fourthrev Ltd.
Fourthrev Ltd. Packaged SoftwareTechnology Services Operates as an educational technology company that provides online learning program services | Grundare | 2014-03-01 |
| BARCLAYS PLC | Företagsledare/Principal | 2012-01-01 |
| ░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░░░░ | - |
| ░░░░░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 13 |
|---|---|
Arbutus Biopharma Corp.
Arbutus Biopharma Corp. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics which targets viral diseases | Health Technology |
Roivant Sciences Ltd.
Roivant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company through its subsidiaries develops restorative therapies for autoimmune diseases | Health Technology |
Barclays PLC
Barclays PLC Investment Banks/BrokersFinance Operates as a bank holding company whose subsidiaries engages in retail banking, credit cards, corporate and investment banking and wealth management services | Finance |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Harvard College
Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Roivant Sciences GmbH
Roivant Sciences GmbH Pharmaceuticals: MajorHealth Technology Develops and markets biopharmaceutical products | Health Technology |
Datavant, Inc.
Datavant, Inc. Packaged SoftwareTechnology Services Operates as a health care software data platform company | Technology Services |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Health Technology |
Urovant Sciences Ltd.
Urovant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for urologic conditions | Health Technology |
Sumitovant Biopharma, Inc.
Sumitovant Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets drugs | Health Technology |
Montes Archimedes Acquisition Corp.
Montes Archimedes Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Fourthrev Ltd.
Fourthrev Ltd. Packaged SoftwareTechnology Services Operates as an educational technology company that provides online learning program services | Technology Services |
Roivant Social Ventures, Inc.
Roivant Social Ventures, Inc. Roivant Social Ventures, Inc. is a not-for-profit social impact organization dedicated to advancing health equity by applying private sector strategies to biopharma innovation and healthcare delivery. The private company is based in New York, NY. The company focuses on ensuring equitable access to medicines and medical care regardless of geography, wealth, or insurance status by investing in early-stage companies developing therapies for underserved patient populations, incubating healthcare-focused social entrepreneurs, and embedding drug development education in academic institutions through fellowships and internships to promote diversity in the biopharma industry and clinical trials. Roivant Social Ventures also partners with companies, institutes, and organizations to create systemic improvements in healthcare access and delivery, with key focus areas including gene therapy access, increasing diversity in clinical trials, and fostering diversity, equity, and inclusion opportunities for future biopharma leaders. Lindsay Androski has been the CEO of the company since 2016. |
Välj din utgåva
All finansiell information anpassad till den nationella nivån